DLDavid C. Lewis

David C. Lewis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


David C. Lewis has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The marks of an apostle

    by David Lewis

    Recent writings by Emanuel Prinz and Alison Goldhor have sought to develop a ‘blueprint’ for mission trainers on the basis of personality traits and spiritual competencies of movement catalysts. This article re-examines the basis on which such assertions are made, not only in terms of questionable methodology but also in the extent to which Western-based psychological models are relevant for other cultural contexts. It also discusses the dangers of toxic leadership and suggests some biblically based criteria for identifying such people.

  • Development of acute inhalation reference exposure levels (RELs) to protect the public from predictable excursions of airborne toxicants

    by James F. Collins, George V. Alexeeff, David C. Lewis, Daryn E. Dodge, Melanie A. Marty, Thomas R. Parker, John D. Budroe, Richard H.F. Lam, Michael J. Lipsett, Jefferson R. Fowles, et al.

    Uniform guidelines have been developed for the derivation of 1‐h acute inhalation reference exposure levels (RELs) applicable to the general public exposed routinely to hazardous substances released into the environment. Existing acute exposure guidance values developed by other organizations have been examined, and strengths and weaknesses in these existing guidelines have been identified. The results of that examination have led to the development of a reproducible and resource‐intensive methodology to calculate acute inhalation RELs for 41 prioritized chemicals. Approaches to estimating levels protective against mild and severe acute effects are discussed in this report. The default methodology is the no‐observed‐adverse‐effect level (NOAEL)/uncertainty factor (UF) approach using mainly reports in the peer‐reviewed toxicological and medical literature. For two well‐studied chemicals, ammonia and formaldehyde, the data allowed a benchmark dose (or concentration) methodology, as a departure from the default options, to be used. However, better human dose–response data from, for example, improved workplace monitoring correlated with symptoms, and more extensive epidemiological studies are needed before the departure from default approaches can be expanded to more substances. Copyright © 2004 John Wiley & Sons, Ltd.